Biotechnology Innovation Organization· @IAmBiotech · X·· 19 天前AI 评分18
AI 导读
在 BIO 2026 的一场专题讨论上，生物技术和制药行业领袖表示，AI 驱动的基因序列分析——即生成式基因组学——有望将药物研发周期从数年缩短至数月。http://Bio.News 解析了研究人员要信任这些模型需要具备哪些条件：https://bio.news/latest-news/bio-2026-generative-genomics-helps-biotechs-design-better-not-just-faster/
正文
AI-driven analysis of genetic sequences - known as generative genomics - could shorten drug development timelines from years to months, according to biotech and pharma leaders at a BIO 2026 panel. http://Bio.News breaks down what it will take for researchers to trust the models: https://bio.news/latest-news/bio-2026-generative-genomics-helps-biotechs-design-better-not-just-faster/
来源：Biotechnology Innovation Organization · x.com